Equity Investment
Oriza Seed is a professional early-stage equity investment platform of Oriza Holdings. As an early project management team of Oriza Holdings, Oriza Seed focuses on investing early-stage and growth-stage start-ups in the fields of Healthcare and TMT. It currently has subsidiaries or offices in Suzhou, Shanghai, Hangzhou, Guangzhou, Nanjing and Beijing, to discover and cultivate high quality projects in those cities and surrounding areas. After development for more than 10 years, Oriza Seed has summarized a set of experiences in early project evaluation, project risk control, project cultivating and value-added services. Meanwhile it has accumulated rich industrial and financial resources, and developed and experienced professional investment team.
The investment style of Oriza Seed emphasizes on early stage, technology and commitment. Oriza Seed has a good reputation among early high-tech start-ups and a professional investment team in the field of healthcare with rich experience and resources.
Since the establishment of Oriza Seed in 2013, the investment style focuses on the early stage, prefers technology, keeps promises, and enjoys a good reputation in the early stage start-up enterprises of technology. At present, it has invested in more than 300 enterprises, and is committed to injecting the strength of growth for entrepreneurial enterprises and growing together with entrepreneurs.
Partner
-
Jianjiang Fei
General Manager, Managing Partner
He is one of the founders of Oriza Holdings and has served as the Executive Vice President of Oriza Holdings, General Manager of Sinova Venture Capital and Co-Chairman of Huayi Fund. Mr Fei focuses on information technology, healthcare and other industries, and has led numerous investment projects, focusing on high-tech and high-growth small and medium-sized enterprises (SMEs) with independent innovation capability, incubating SMEs, and creating a perfect industrial chain and high-tech industry clusters. Mr Fei has been engaged in venture capital investment for nearly 20 years, with a total investment amount of billions of RMB and a number of high-quality enterprises listed both domestically and internationally, achieving great results. He has led the investment in hundreds of projects such as Shenzhou Information (000555), Jingfang Technology (603005), Maddie Technology (603990), Cinda Bio (HK1801) and so on. -
Qun Zhao
Healthcare Partner
He has 14 years of management experience in three pharmaceutical companies, including chemical, traditional Chinese medicine, biopharmaceuticals and vaccines. He has good communication channels with R&D organisations, manufacturing companies and regulatory authorities in the pharmaceutical industry. Leading projects: Keystone Pharmaceuticals (HK2616), Ascent Pharmaceuticals (HK6855), WuXiMing Juno (HK2126), Bekom Healthcare (HK2170), Shinemax Biologics, Qidian Pharmaceuticals, BioSetu, XinGeYuan, etc. -
Mingda Jiang
TMT Partner
He was the investment director of Sinovation Venture Capital and the investment director of Huayi Fund, and previously worked for Cisco, Fujitsu and other IT companies. With more than 10 years of investment management experience, he mainly focuses on investments in the fields of science and technology, intelligent manufacturing and supply chain. Leading projects: Jiangsu Beiren (688218), Tianjun Technology (688003), Wenyuan Zhixing, Just-in-Time, ZhiCast Communications, Ulexa, Necessity, Daxidi, etc. -
Jinxin Le
TMT Partner
Formerly a regional partner of Oriza Seed in Nanjing, he has nearly 10 years of investment management experience in the TMT field, and has deep industrial knowledge and human resources in the fields of AI, IC, and intelligent manufacturing. The leading investment projects include: Unicorn Cambrian (688256), Cloud from Technology; Xi Zhi Technology, Le Rhyme Rui Technology, Regent Star Technology, Elite Robotics, Silicon Micro, Han World and so on. -
Di Wu
Partner,COO
Ms. Wu Di is fully responsible for the company's operations and risk control. She currently serves as the Secretary-General of the Suzhou Fund Industry Association.
With nearly 20 years of experience in the financial sector and hands-on investment practice, Ms. Wu previously held the position of Middle and Back Office Partner at Suzhou Fund, where she made strategic investments in leading funds including Qiming Venture Partners, Cathay Capital, and Lilly Asia Ventures. She also served as Deputy President at Yipu Capital, during which she led the establishment of the Dreame Yipu Industrial Incubation Fund.
Her investment portfolios include Magic Atom, Cybrid Technologies, Jinhong Gas, Neway Valve, and Tantuo Technology, all of which have grown into industry benchmark enterprises. -
Aiying Yang
Guangzhou Regional Partner
She is responsible for project investment and management in South China. She entered the investment industry in 2008: she has served as deputy director of Jiuding Investment, assistant vice president of CDH Venture Capital, investment director of Yuexiu Industrial Investment, and has a master degree from Tsinghua University. Investment projects: Xingyuan Material (300568), Beida Road (Unnamed Medical 002581.sz), Aojida Medical, Suoyuan Bio, Yizi Home, Pai Zhen Bio, An Jisheng Medical, Ruipai Medical, Shenzhen Lizhe, Mushroom IOT and so on. -
Min Du
Suzhou Regional Partner
He has different working experience in communication, financial payment and machinery industry, participated in IPD process reengineering, and has rich experience in R&D management and brand marketing. Since engaging in the investment industry, he has focused on research and investment in the direction of communication, intelligent manufacturing and big data, and has worked closely with major investment carriers and incubators in Suzhou. He has invested in companies such as SmartCast Communications, Hai Guang Xin Chuang, Trondat, Huibo Robotics, Yuan Zhuo Optoelectronics, and SIG Data. -
Fei Mi
Beijing Regional Partner
Responsible for project investment and management in Beijing and surrounding areas. MBA tutor in finance at Cheung Kong Graduate School of Business. Previously worked for the State Administration of Cultural Heritage, Motorola (China), Meituan and other companies, many years of experience in Internet entrepreneurship, leading investments: Traveljoy Group, Lingkong Tianxing, Xi Zhi Technology, with the light of the science and technology, Super Zero, MAOPEA, Xiaoman Chatian and so on. -
Ding Zheng
Hangzhou Regional Partner
He holds a Master's degree in Materials Science from the University of Rochester, USA. He was the General Manager of Plug and Play Hangzhou, and co-founded Huadao Venture Capital, where he invested in and incubated high-tech start-ups including Woodchain Technology and Insight Intelligence. He focuses on early-stage technology innovation and application in cross-disciplinary fields. -
Bing Zhu
NanTong Regional Partner
He holds a Ph.D. in Mechanical and Electrical Engineering from Nanjing Tech University and an EMBA from Shanghai Jiao Tong University (Antai College). He joined Oriza Seed in 2014 and has since served as Investment Manager, Investment Director, and Partner, focusing on investments in advanced technology, industrial technology, and AI-related fields with extensive investment experience.
He has led investments in numerous projects, including TZTEK (688003), Zhixing Automotive Technology (HK1274), WeRide (WRD.US), Cloudwalk (688327), SITUOS, Mushroom IoT, and TuringQ. He has been recognized as one of the "40 Under 40 Investors" by Cyzone and honored as a Suzhou Professional Equity Investment Talent. -
Wenlong Sun
Venture Partner
He is responsible for the company's operation and risk control. He is a doctor of finance from Fudan University and a certified public accountant in the PRC. He has worked in software development and implementation at UFIDA Software and financial management at the finance department of China UnionPay. He joined Oriza Holdings in 2008 to start the management of equity investment and has more than 10 years of management experience, with in-depth research and accumulation of experience in the areas of operation and management of the company, fund structure, risk control, etc. He is responsible for the operation and risk control of the company.